Archives

Would you like to present your work at the TBVI Annual Symposium? To encourage promising scientists and recognise outstanding contributions to TB vaccine research and development, TBVI presents [...]

Following the call for vaccine researchers to submit their vaccine candidate for testing in a mouse model, we are delighted to announce the selection of three candidates. Based on predetermined [...]

On May 27-28 2024, the second progress meeting of the MTBVACN3 project took place in Pilanesberg, near Johannesburg in South Africa. During these days the consortium partners met to share [...]

Biofabri and TBVI have signed a contract with the European Health and Digital Executive Agency (HaDEA) under the EU4Health Programme to accelerate the final development of the MTBVAC vaccine. [...]

TBVI has an exciting career opportunity for a motivated individual to join the organisation as Scientific Project Manager (full-time or part-time). You will join a small, enthusiastic team, [...]

TBVI has an exciting position as Management Assistant (full-time or part-time). You will join a small, enthusiastic team, dedicated to TBVI’s goals to relieve the burden of TB and eliminate [...]

As we believe that no one should be left out of the conversation, we offer travel and registration support (participant support) for participants planning to attend the 7th Global Forum on TB [...]

Diversification of the vaccine development pipeline has been identified as a priority area in the Global TB Vaccine R&D Roadmap. The TBVAC-HORIZON consortium aims, amongst other things, to [...]

TBVAC-HORIZON has met an important milestone: On 3 April 2024, the first participant in the UOXF “TB46” study was enrolled. Tuberculosis (TB) remains one of the most devastating infectious [...]

The Global Forum on TB Vaccines will take place from 8-10 October 2024 and will be hosted in Rio de Janeiro, Brazil. The Call for Abstracts for the 7th Global Forum on TB Vaccines is now [...]